Bile acids and microbes in metabolic disease |
| |
Authors: | Dhiraj Kumar Sah Archana Arjunan Sun Young Park Young Do Jung |
| |
Institution: | Dhiraj Kumar Sah, Archana Arjunan, Young Do Jung, Department of Biochemistry, Chonnam National University, Gwangju 501190, South KoreaSun Young Park, Department of Internal Medicine, Chonnam National University, Gwangju 501190, South Korea |
| |
Abstract: | Bile acids (BAs) serve as physiological detergents that enable the intestinal absorption and transportation of nutrients, lipids and vitamins. BAs are primarily produced by humans to catabolize cholesterol and play crucial roles in gut metabolism, microbiota habitat regulation and cell signaling. BA-activated nuclear receptors regulate the enterohepatic circulation of BAs which play a role in energy, lipid, glucose, and drug metabolism. The gut microbiota plays an essential role in the biotransformation of BAs and regulates BAs composition and metabolism. Therefore, altered gut microbial and BAs activity can affect human metabolism and thus result in the alteration of metabolic pathways and the occurrence of metabolic diseases/syndromes, such as diabetes mellitus, obesity/hypercholesterolemia, and cardiovascular diseases. BAs and their metabolites are used to treat altered gut microbiota and metabolic diseases. This review explores the increasing body of evidence that links alterations of gut microbial activity and BAs with the pathogenesis of metabolic diseases. Moreover, we summarize existing research on gut microbes and BAs in relation to intracellular pathways pertinent to metabolic disorders. Finally, we discuss how therapeutic interventions using BAs can facilitate microbiome functioning and ease metabolic diseases. |
| |
Keywords: | Bile acids Metabolic diseases Gut microbe Diabetic mellitus Obesity Hypercholesterolemia |
|
| 点击此处可从《世界胃肠病学杂志(英文版)》浏览原始摘要信息 |
|